117 related articles for article (PubMed ID: 38218360)
1. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway.
Yan Y; Wang S; Zhang Z; Tang M; Zhao AZ; Li Z; Wu X; Li F
Arch Biochem Biophys; 2024 Feb; 752():109891. PubMed ID: 38218360
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR.
Peng L; Liang D; Tong W; Li J; Yuan Z
J Biol Chem; 2010 Jul; 285(27):20870-81. PubMed ID: 20439463
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of E2F1 in the proliferation, migration, and invasion of endometrial carcinoma cells via the regulation of BMI1 transcription.
Lu Y; Wei Y; Shen X; Tong Y; Lu J; Zhang Y; Ma Y; Zhang R
Genes Genomics; 2023 Nov; 45(11):1423-1431. PubMed ID: 37646913
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
6. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
7. Silencing FKBP38 gene by siRNA induces activation of mTOR signaling in goat fetal fibroblasts.
Fu YT; Zheng X; He Q; Jia XY; Guo ZX; Yao RY; Wang YF; Wang ZG
Genet Mol Res; 2015 Aug; 14(3):9675-82. PubMed ID: 26345900
[TBL] [Abstract][Full Text] [Related]
8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch.
Chen Q; Schatz C; Cen Y; Chen X; Haybaeck J; Li B
Taiwan J Obstet Gynecol; 2022 Sep; 61(5):780-787. PubMed ID: 36088044
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer.
Liao Y; He X; Qiu H; Che Q; Wang F; Lu W; Chen Z; Qiu M; Wang J; Wang H; Wan X
BMC Cancer; 2014 Jul; 14():487. PubMed ID: 24997474
[TBL] [Abstract][Full Text] [Related]
11. Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer.
Wu J; Cheng Z; Xu X; Fu J; Wang K; Liu T; Wu C; Kong X; Yang Q; Yan G; Zhou H
Front Oncol; 2019; 9():422. PubMed ID: 31192127
[TBL] [Abstract][Full Text] [Related]
12. Tripartite motif containing 28 (TRIM28) promotes the growth and migration of endometrial carcinoma cells by regulating the AKT/mTOR signaling pathway.
Chen Y; Cheng H; Long H
Gen Physiol Biophys; 2021 May; 40(3):245-252. PubMed ID: 34100380
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolic acid induces apoptosis and autophagy of endometrial carcinoma cells via inhibiting PI3K/Akt/mTOR pathway in vivo and in vitro.
Zhou L; Li S; Sun J
Hum Exp Toxicol; 2021 Dec; 40(12):2156-2164. PubMed ID: 34132136
[TBL] [Abstract][Full Text] [Related]
14. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
Dunlop EA; Dodd KM; Seymour LA; Tee AR
Cell Signal; 2009 Jul; 21(7):1073-84. PubMed ID: 19272448
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.
Yoon MS; Sun Y; Arauz E; Jiang Y; Chen J
J Biol Chem; 2011 Aug; 286(34):29568-74. PubMed ID: 21737445
[TBL] [Abstract][Full Text] [Related]
17. Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway.
Xing M; Wu B; Wang S
Reprod Sci; 2023 Feb; 30(2):590-600. PubMed ID: 35859224
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
Cao X; He GZ
Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
[TBL] [Abstract][Full Text] [Related]
20. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
Huang J; Sun X; Diao G; Li R; Guo J; Han J
Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]